Erratum to: Human Wharton's Jelly Stem Cells and Its Conditioned Medium Enhance Healing of Excisional and Diabetic Wounds: Human Wharton's Jelly Stem Cells and Wound Healing (Journal of Cellular Biochemistry, (2014), 115, 2, (290-302), 10.1002/jcb.24661);Human Wharton's jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds

Journal of Cellular Biochemistry

Volumn 115, Issue 2, 2014, Pages 290-302

  Fong, Chui Yee ^a   Tam, Kimberley ^a   Cheyyatraivendran, Suganya ^a   Gan, Shu Uin ^a   Gauthaman, Kalamegam ^a   Armugam, Arunmozhiarasi ^a   Jeyaseelan, Kandiah ^a   Choolani, Mahesh ^a   Biswas, Arijit ^a   Bongso, Ariff ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Excisional and Diabetic Wounds; Human Wharton's Jelly Stem Cells (hWJSCs); hWJSC Conditioned Medium; Scratch Wound Assay; Wound Healing; Xenograft Murine Model

Indexed keywords

COLLAGEN; CYTOKERATIN; ELASTIN; FIBRONECTIN; FILAGGRIN; GREEN FLUORESCENT PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INVOLUCRIN; MICRORNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN A;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL DIFFERENTIATION; CELL INVASION; CELL ISOLATION; CELL MIGRATION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; DIABETIC WOUND; EMBRYO; EPITHELIZATION; EXCISION; FEMALE; HAIR FOLLICLE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; KERATINOCYTE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBACEOUS GLAND; SKIN BIOPSY; SKIN FIBROBLAST; TISSUE REPAIR; WOUND HEALING;

MURINAE;

EXCISIONAL AND DIABETIC WOUNDS; HUMAN WHARTON'S JELLY STEM CELLS (HWJSCS); HWJSC CONDITIONED MEDIUM; SCRATCH-WOUND ASSAY; WOUND HEALING; XENOGRAFT MURINE MODEL;

AGED; ANIMALS; CELL- AND TISSUE-BASED THERAPY; CULTURE MEDIA, CONDITIONED; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GENE EXPRESSION; HETEROGRAFTS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICRORNAS; STEM CELLS; UMBILICAL CORD; WOUND HEALING;

EID: 84890501161     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.26081     Document Type: Erratum

References (57)

1. Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P,. 2003. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 196: 245-250.
2. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H,. 2009. The role of vascular endothelial growth factor in wound healing. J Surg Res 153: 347-358.
3. Bey E, Prat M, Duhamel P, Benderitter M, Brachet M, Trompier F,. 2010. Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen 18: 50-58.
4. Bielefeld KA, Amini-Nik S, Whetstone H, Poon R, Youn A, Wang J,. 2011. Fibronectin and β-catenin act in a regulatory loop in dermal fibroblasts to modulate cutaneous healing. J Cell Biochem 286: 27687-27697.
5. Bongso A, Fong CY,. 2013. The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord. Stem Cell Rev Rep 9: 226-240.
6. Borue X, Lee S, Grove J, Herzog EL, Harris R, Diflo T,. 2004. Bone marrow-derived cells contribute to epithelial engraftment during wound healing. Am J Pathol 165: 1767-1772.
7. Chen L, Tredget EE, Liu C, Wu Y,. 2009. Analysis of allogenecity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS ONE 4: e7119.
8. Clark RAF,. 1990. Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin. J Invest Dermatol 94: 128S-134S.
9. Cory G,. 2011. Scratch-wound assay. Methods Mol Biol 769: 25-30.
10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D,. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
11. Estes JM, Adzick NS, Harrison MR, Longaker MT, Stern R,. 1993. Hyaluronate metabolism undergoes an ontogenic transition during fetal development: Implications for scar-free wound healing. J Pediatr Surg 28: 1227-1231.
12. Fan CG, Zhang Q, Zhou J,. 2011. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev Rep 7: 195-207.
13. Fathke C, Wilson L, Hutter J, Kapoor V, Smith A, Hocking A,. 2004. Contribution of bone marrow-derived cells to skin: Collagen deposition and wound repair. Stem Cells 22: 812-822.
14. Fong CY, Richards M, Manasi N, Biswas A, Bongso A,. 2007. Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reprod BioMed Online 15: 708-718.
15. Fong CY, Subramanian A, Biswas A, Gauthaman K, Srikanth P, Hande MP, Bongso A,. 2010. Derivation efficiency, cell proliferation, frozen-thaw survival, stem-cell properties, and differentiation of human Wharton's jelly stem cells. Reprod BioMed Online 21: 391-401.
16. Fong CY, Chak LL, Biswas A, Tan JH, Gauthaman K, Chan WK, Bongso A,. 2011. Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev Rep 7: 1-16.
17. Fong CY, Gauthaman K, Cheyyatraivendran S, Lin HD, Biswas A, Bongso A,. 2012. Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo. J Cell Biochem 113: 658-668.
18. Gauthaman K, Fong CY, Suganya CA, Subramanian A, Biswas A, Choolani M,. 2012. Extra-embryonic human Wharton's jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells. Reprod Biomed Online 24: 235-246.
19. Gay AN, Mushin OP, Lazar DA, Naik-Mathuria BJ, Ling Yu, Gobin A,. 2011. Wound healing characteristics of ICAM-1 null mice devoid of all isoforms of ICAM-1. J Surg Res 171: e1-e7.
20. Harris DT, Hilgaertner J, Simonson C, Ablin RJ, Badowski M,. 2012. Cell-based therapy for epithelial wounds. Cytotherapy 14: 802-810.
21. Jackson WM, Nesti LJ, Tuan RS,. 2012. Concise review: Clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med 1: 44-50.
22. Jager R, Fearnhead HO,. 2012. Dead cells talking: The silent form of cell death is not so quiet. Biochem Res Int, doi: 10.1155/2012/453838
23. Jeon YK, Jang YH, Yoo DR, Kim SN, Lee SK, Nam MJ,. 2010. Mesenchymal stem cells interaction with skin: Wound-healing effect on fibroblast cells and skin tissue. Wound Repair Regen 18: 655-661.
24. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H,. 2007. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 100: 1579-1588.
25. Jin G, Prabhakaran MP, Ramakrishna S,. 2011. Stem cell differentiation to epidermal lineages on electrospun nanofibrous substrates for skin tissue engineering. Acta Biomater 7: 3113-3122.
26. Karolina DS, Armugam A, Tavintharan S, Wong M, Lim SC, Sum CF,. 2011. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS ONE 6: e22839.
27. Kim SW, Zhang HZ, Guo L, Kim JM, Kim MH,. 2012. Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities. PLoS ONE 7: e41105.
28. Kuo YR, Wang CT, Cheng JT, Wang FS, Chiang YC, Wang CJ,. 2011. Bone marrow-derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes. Plast Reconstr Surg 128: 872-880.
29. La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M,. 2009. Isolation and characterization of OCT4+/HLA-G+ mesenchymal stem cells from the human umbilical cord matrix: Differentiation potential and detection of new markers. Histochem Cell Biol 131: 267-282.
30. Li F, Huang Q, Chen J, Peng Y, Roop D, Bedford J,. 2010. Apoptotic cells activate the 'Phoenix rising' pathway to promote wound healing and tissue regeneration. Sci Signal 3: ra13.
31. Liao B, Bao X, Liu L, Feng S, Zovoilis A, Liu W,. 2011. MicroRNA cluster 302-367 enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transition. J Cell Biochem 286: 17359-17364.
32. Liu Y, Min D, Bolton T, Nubé V, Twigg SM, Yue DK,. 2009. Increased matrix metaloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care 32: 117-119.
33. Lorenz HP, Longaker MT, Perkocha LA, Jennings RW, Harrison MR, Adzick NS,. 1992. Scarless wound repair: A human fetal skin model. Development 114: 253-259.
34. Luo G, Cheng W, He W, Wang X, Tan J, Fitzgerald M,. 2010. Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood. Wound Repair Regen 18: 506-513.
35. Nagaoka T, Kaburagi Y, Hamaguchi Y, Hasegawa M, Takehara K, Steeber DA,. 2000. Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am J Pathol 157: 237-247.
36. Madhyastha R, Madhyastha H, Nakajima Y, Omura S, Maruyama M,. 2012. MicroRNA signature in diabetic wound healing: Promotive role of miR-21 in fibroblast migration. Int Wound J 9: 355-361.
37. Martin P, D'Souza D, Martin J, Grose R, Cooper L, Maki R,. 2003. Wound healing in the PU.1 null mouse-Tissue repair is not dependent on inflammatory cells. Curr Biol 13: 1122-1128.
38. Mathieu D, Linke JC, Wattel F,. 2006. Non-healing wounds. In:, Mathieu DE, editor. Handbook on hyperbaric medicine. Amsterdam, The Netherlands: Springer. pp 401-428.
39. Maxson S, Lopez EA, Yoo D, Danilkovitch-Miagkova A, Leroux MA,. 2012. Concise review: Role of mesenchymal stem cells in wound repair. Stem Cells Transl Med 1: 142-149.
40. Muller M, Trocme C, Lardy B, Morel F, Halimi S, Benhamou PY,. 2008. Matrix metalloproteinases and diabetic foot ulcers: The ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Diabet Med 25: 419-426.
41. Pappa KI, Anagnou NP,. 2009. Novel sources of fetal stem cells: Where do they fit on the developmental continuum ? Future Med 4: 423-433.
42. Rnjak J, Wise SG, Mithieux SM, Anthony S, Weiss AS,. 2011. Severe burn injuries and the role of elastin in the design of dermal substitutes. Tissue Eng Part B Rev 17: 81-91.
43. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H,. 2008. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 180: 2581-2587.
44. Schneider RK, Püllen A, Kramann R, Bornemann J, Knüchel R, Neuss S,. 2010. Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents. Differentiation 79: 182-193.
45. Shin L, Peterson DA,. 2013. Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells. Stem Cells Transl Med 2: 33-42.
46. Stevens LJ, Page-McCaw A,. 2012. A secreted MMP is required for reepithelialisation during wound healing. Mol Biol Cell 23: 1068-1079.
47. Stoff A, Rivera AA, Sanjib Banerjee, Moore N, Michael ST, Numnum T, Espinosa-de-Los-Monteros A,. 2009. Promotion of incisional wound repair by human mesenchymal stem cell transplantation. Exp Dermatol 18: 362-369.
48. Suarez Y, Hernando CF, Yu J, Gerber S, Harrison K, Pober J,. 2008. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci USA 105: 14082-14087.
49. Sullivan SR, Underwood RA, Gibran NS, Sigle RO, Usui ML, Carter WG,. 2004. Validation of a model for the study of multiple wounds in the diabetic mouse (db/db). Plast Reconstr Surg 113: 953-960.
50. Taghizadeh RR, Cetrulo KJ, Cetrulo CL,. 2011. Wharton's jelly stem cells: Future clinical applications. Placenta 32: S311-S315.
51. Troyer DL, Weiss ML,. 2008. Concise review: Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26: 591-599.
52. Walter MN, Wright KT, Fuller HR, MacNeil S, Johnson WE,. 2010. Mesenchymal stem cell-conditioned medium accelerates skin wound healing: An in vitro study of fibroblast and keratinocyte scratch assays. Exp Cell Res 316: 1271-1281.
53. Wang XY, lan Y, He WY, Zhang L, Yao HY, Hou C,. 2008. Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos. Blood 111: 2436-2443.
54. Wang Y, Han ZB, Ma J, Zuo C, Geng J, Gong W,. 2012. A toxicity study of multiple-administration human umbilical cord mesenchymal stem cells in cynomolgus monkeys. Stem Cells Dev 21: 1401-1408.
55. Wu Y, Chen L, Scott PG, Tredget EE,. 2007. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25: 2648-2659.
56. Yukami T, Hasegawa M, Matsushita Y, Fujita T, Matsushita T, Horikawa M,. 2007. Endothelial selectins regulate skin wound healing in cooperation with L-selectin and ICAM-1. J Leukoc Biol 82: 519-531.
57. Zhang K, Garner W, Cohen L, Rodriguez J, Phan S,. 1995. Increased Types I and III collagen and transforming growth factor- 1 mRNA and protein in hypertrophic burn scar. J Investig Dermatol 104: 750-754.